Access to medicines

: Steven Lott
: September 11, 2012

Collaboration Between Indian and 
Multi-National Pharmaceutical Companies

The greatest area of growth for India’s domestic pharmaceutical industry has been in the U.S. and other established markets.  Similarly, the growth of multi-... More »
: Access to medicines, Articles, Emerging markets, Global, India, innovation
: Steven Lott
: August 27, 2012

PhRMA Disputes Claim that Response to Cancer Drug Shortage is a Compulsory License

From Pharmaceutical Research and Manufacturers of America (PhRMA)August 24, 2012 Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President of... More »
: Access to medicines, Articles, Compulsory licensing, India, Intellectual property
: Steven Lott
: August 8, 2012

Five questions to ask about India’s proposed free drugs programme

The following article is reprinted with permission from Guari Kamath, creator of the Apothecurry blog.  Gauri Kamath has been writing on the business of... More »
: Access to medicines, Articles, Generic medicines, India
: Kristina Lybecker
: July 27, 2012

Beyond Glivec : Balancing innovation and public health

The following article is reprinted with permission from Guari Kamath, creator of the Apothecurry blog.  Gauri Kamath has been writing on the business of... More »
: Access to medicines, Articles, India, innovation, Intellectual property
: Kristina Lybecker
: December 22, 2011

The Economics of Access to Medicines: Meeting the Challenges of Pharmaceutical Patents, Innovation, and Access for Global Health

Neglected diseases impose a tremendous burden on global health.  One that is disproportionally borne by the poor and vulnerable.  Each year more than 18... More »
: Access to medicines, Global, Global health, innovation, Intellectual property, Research papers
: Susan Huggett
: June 10, 2011

CBO report: further restricting DTC advertising may be bad for public health

Guest blog by Susan Huggett, President of Torre Lazur McCann Canada Periodically, there have been calls for greater limits on direct to consumer (DTC) advertising... More »
: Access to medicines, Articles, DTC advertising, innovation, USA
: Steven Lott
: October 24, 2010

Advancing Access to Newer Treatments for Atrial Fibrillation

Presentation at the Canadian Cardiovascular Society Congress, attended by Steven Lott, Siobhan Cavanaugh (Associate) and Wayne Taylor (ED, Cameron Institute).... More »
: Access to medicines, Atrial Fibrillation, Canada, Presentations
: Steven Lott
: August 11, 2010

Canada is slow to adopt innovative medicines, according to new study

According to a recently released report comparing international usage of prescription drugs, Canada ranks second-last (thirteenth out of 14 countries). The report... More »
: Access to medicines, Articles, Canada
: Elisabeth Fowler
: November 4, 2009

Accessing Drugs for Rare Diseases in Canada: The Patient Perspective

Elisabeth Fowler delivered the attached presentation at the Drug Information Association conference in Ottawa, Canada in November, 2009. The presentation covered... More »
: Access to medicines, Canada, Presentations, Rare Disorders
: Elisabeth Fowler
: September 20, 2009

How are new drugs developed?

World Health Advocacy co-hosted the "Access to Rx Drugs:  What Every Patient Should Know" workshop held in Toronto, ON on September 21 & 22, 2009. ... More »
: Access to medicines, Canada, innovation, Presentations